Back to search

Peptide record

TPDB43950

Antiviral standard
21 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB43950
Antiviral
Anti-infective peptides
AI4AVP DRAVP 2.0 Peptipedia
standard
No
A 21-aa standard-residue antiviral peptide sequence curated from AI4AVP, DRAVP 2.0, and Peptipedia, with an available 3D structural model.
Sequence
PTLLFLKVPAQNAISTTFPYT
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C111H172N24O30
RDCEGHMW
T
2322.73
9.74
1
0
10
+1
-0.08
0.414
97.62
Mammalian: >20 hour Yeast: >20 hour E.coli: ?
1490
0.64
8
Residue Composition
number
2
A
0
R
1
N
0
D
0
C
0
E
1
Q
0
G
0
H
1
I
3
L
1
K
0
M
2
F
3
P
1
S
4
T
0
W
1
Y
1
V
Amino Acid Distribution
A: 2 R: 0 N: 1 D: 0 C: 0 E: 0 Q: 1 G: 0 H: 0 I: 1 L: 3 K: 1 M: 0 F: 2 P: 3 S: 1 T: 4 W: 0 Y: 1 V: 1
Chemical Descriptors
21 reviewed residue count
C111H172N24O30 sequence-only estimate (linear, free termini)
2322.73 sequence-only estimate (linear, free termini)
9.74 sequence-only estimate (linear, free termini)
+1 sequence-only estimate (linear, free termini)
-0.08 sequence-only estimate (linear, free termini)
0.414 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

DRAVP 2.0